The inverse relationship between CDH1 and COX2 and its molecular mechanism in tumour cells was demonstrated for the first time in non-small cell lung cancer, in which the inhibition of tumour COX2 with celecoxib led to increased expression of CDH1 (20). This evidence concerns the gene PTGS2 and non-small cell lung carcinoma.